BTRX-246040
BTRX-246040
BTRX-246040 (pronunciation: B-T-R-X-Two-Four-Six-Zero-Four-Zero) is a novel investigational drug currently under development for the treatment of various neurological and psychiatric disorders.
Etymology
The term "BTRX-246040" is a unique identifier given by the developing company, BlackThorn Therapeutics, to this specific investigational compound. The prefix "BTRX" stands for BlackThorn RX, where RX is a common abbreviation for prescription drugs. The numbers "246040" do not have a known specific meaning and are likely a part of an internal coding system.
Pharmacology
BTRX-246040 is a small molecule antagonist of the nociceptin receptor (NOP receptor), a protein that plays a key role in the regulation of mood and reward behavior. By blocking the activity of the NOP receptor, BTRX-246040 is believed to have potential therapeutic effects in conditions such as major depressive disorder (MDD) and post-traumatic stress disorder (PTSD).
Clinical Development
As of the time of writing, BTRX-246040 is in Phase 2 clinical trials for the treatment of MDD and PTSD. The drug has shown promising results in early-stage trials, with a favorable safety profile and potential efficacy in reducing symptoms of these disorders.
Related Terms
- BlackThorn Therapeutics: The biopharmaceutical company responsible for the development of BTRX-246040.
- NOP receptor: The target protein of BTRX-246040, involved in mood and reward behavior.
- Major depressive disorder (MDD): A mental health disorder characterized by persistent feelings of sadness and loss of interest, which BTRX-246040 is being developed to treat.
- Post-traumatic stress disorder (PTSD): A disorder characterized by failure to recover after experiencing or witnessing a terrifying event, which BTRX-246040 is being developed to treat.
External links
- Medical encyclopedia article on BTRX-246040
- Wikipedia's article - BTRX-246040
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski